COYA — Coya Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-12-29.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-08-18 | GOLDSTEIN DOV A MD Director | Option exercise | 17.6K | 1.09 | 19.1K |
| 2024-11-14 | SNYDER DAVID S Chief Financial Officer | Open-market purchase | 1.8K | 7.19 | 12.9K |
| 2024-11-13 | Swaminathan Arun Chief Executive Officer | Open-market purchase | 5.0K | 7.36 | 36.8K |
| 2024-11-11 | Swaminathan Arun Chief Executive Officer | Open-market purchase | 5.0K | 7.34 | 36.7K |
| 2024-11-11 | Grossman Fred Chief Medical Officer | Open-market purchase | 2.7K | 7.37 | 20.0K |
| 2023-08-22 | Lee Ann Director | Open-market purchase | 1.0K | 3.62 | 3.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| DME Capital Management, LP | 9.2M | 2.3M |
| AIGH Capital Management LLC | 3.8M | 975.4K |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | 844.9K |
| Alyeska Investment Group, L.P. | 3.2M | 800.0K |
| Prosight Management, LP | 1.7M | 420.4K |
| CM Management, LLC | 1.5M | 375.0K |
| PRIVATE MANAGEMENT GROUP INC | 1.5M | 369.1K |
| GEODE CAPITAL MANAGEMENT, LLC | 919.8K | 233.4K |
| MARSHALL WACE, LLP | 889.6K | 225.8K |
| VANGUARD FIDUCIARY TRUST CO | 551.2K | 139.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-11 | 2026-08-11 | on EDGAR ↗ |
| 8-K/A | 2026-08-07 | 2026-03-29 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-07-27 | — | on EDGAR ↗ |
| 8-K | 2026-06-25 | 2026-06-25 | on EDGAR ↗ |
| ARS | 2026-05-13 | 2025-12-31 | on EDGAR ↗ |
| DEFA14A | 2026-05-13 | — | on EDGAR ↗ |
| DEF 14A | 2026-05-13 | 2026-06-25 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Coya Therapeutics, Inc. (COYA) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about COYA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →